About Amyloidosis Research Consortium

The Amyloidosis Research Consortium (ARC) is a nonprofit organization dedicated to driving advances in the awareness, science, and treatment of amyloid diseases.
ARC’s mission is to improve and extend the lives of those with amyloidosis.
ARC is committed to collaborative efforts that accelerate the pace of discovery, expand patient access to the most effective care, and improve short- and long-term outcomes.
Working with partners in industry, government, and academia, ARC seeks to spark innovation and to bring promising treatments from labs to clinics.
ARC’s outreach and education inform and empower patients, families, caregivers, physicians, and researchers.